Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial - Concepedia

Concepedia

Publication | Closed Access

Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial

869

Citations

15

References

2007

Year

Alan Menter, Stephen K. Tyring, Kenneth B. Gordon, Alexa B. Kimball, Craig L. Leonardi, Richard G. Langley, Bruce Strober, Martin Kaul, Yihua Gu, Martin M. Okun,

Journal of the American Academy of Dermatology

Autoimmune DiseaseSystemic TreatmentSevere PsoriasisPhase Iii TrialClinical TrialsAdalimumab TherapyClinical DermatologyDermatologyImmunotherapyMedicine

References

	Year	Citations

Page 1

Page 1